Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ATPC | Agape Atp | $4.07 | $2.05 | 101.48% | 49.4M | $2.0M | $1.72$128.25 |
| ACXP | Acurx Pharmaceuticals | $2.82 | $0.87 | 44.25% | 21.1M | $5.0M | $1.33$21.00 |
| MGNX | MacroGenics | $3.06 | $0.70 | 29.45% | 118.1K | $149M | $0.99$3.11 |
| INKT | MiNK Therapeutics | $13.42 | $2.97 | 28.42% | 220.8K | $49M | $6.34$76.00 |
| TTEC | TTEC Holdings | $3.16 | $0.67 | 26.91% | 41.6K | $121M | $1.98$5.60 |
| PIII | P3 Health Partners | $3.65 | $0.77 | 26.52% | 249.9K | $9.5M | $1.52$11.30 |
| AGCC | Agencia Comercial Spirits | $22.10 | $3.90 | 21.43% | 18.5K | $626M | $3.66$24.98 |
| LFMD | LifeMD | $3.77 | $0.65 | 20.83% | 72.7K | $150M | $2.56$15.84 |
| PLYX | Polaryx Therapeutics | $4.23 | $0.71 | 20.17% | 351.3K | $167M | $2.20$48.91 |
| ZVRA | Zevra Therapeutics | $10.95 | $1.83 | 20.07% | 169K | $513M | $6.19$13.16 |
| IXHL | Incannex Healthcare | $5.07 | $0.84 | 19.86% | 31.1K | $49M | $2.40$49.80 |
| OCC | Optical Cable | $7.26 | $1.15 | 18.82% | 316.4K | $54M | $2.40$11.50 |
| AXTI | AXT | $45.53 | $6.97 | 18.08% | 378K | $2.1B | $1.13$47.03 |
| FGI | Fgi Industries | $4.01 | $0.60 | 17.66% | 6.2K | $6.5M | $2.28$12.62 |
| GEMG | Themes ETF Trust - Leverage Shares 2x Long Gemi Daily ETF | $2.97 | $0.44 | 17.45% | 46.3K | - | $1.13$17.73 |
| TENX | Tenax Therapeutics | $12.90 | $1.88 | 17.06% | 19.4K | $69M | $4.63$18.38 |
| TKNO | Alpha Teknova | $2.47 | $0.35 | 16.51% | 7.6K | $114M | $1.91$7.48 |
| VYGR | Voyager Therapeutics | $4.74 | $0.63 | 15.33% | 63.5K | $229M | $2.65$5.55 |
| FUTG | Themes ETF Trust - Leverage Shares 2x Long Futu Daily ETF | $11.69 | $1.47 | 14.38% | 109.4K | - | $9.46$22.90 |
| CRMU | Themes ETF Trust - Leverage Shares 2x Long Crml Daily ETF | $8.69 | $1.09 | 14.37% | 21.4K | - | $6.52$15.25 |
| GITS | Global Interactive Technologies | $2.58 | $0.32 | 14.03% | 76.3K | $8.3M | $0.66$7.09 |
| ARTL | Artelo Biosciences | $3.95 | $0.44 | 12.54% | 90.2K | $7.5M | $3.15$85.80 |
| UECG | Themes ETF Trust - Leverage Shares 2x Long Uec Daily ETF | $10.05 | $0.97 | 10.69% | 17.5K | - | $7.57$15.46 |
| APPX | Investment Managers Series Trust II - Tradr 2x Long App Daily ETF | $41.60 | -$6.55 | -13.60% | 420.6K | - | $20.21$157.62 |
Related Articles
Featured Article
1 Small-Cap Stock I'd Buy Before GLBE in 2026
Marc Guberti|Jan 8, 2026
Global-E Online is a small company trying to carve out a niche in the competitive e-commerce space, while AXT is a small semiconductor player that already has a lead in an emerging opportunity.
2 Biotech Stocks That Could Make You Richer
James Halley|Jul 14, 2023
These biotech companies are seeing a spike in revenue growth.
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Keith Speights|Mar 19, 2022
Voyager Therapeutics has promising technology. But the stock is very risky.
Parkinson's Disease Patients Get Long-Term Benefits From Experimental Gene Therapy
Cory Renauer|Sep 11, 2020
Three years after treatment with NBIb-1817, Parkinson's disease patients still are still showing improvements.
Is Now a Good Time To Buy Neurocrine Biosciences?
James Halley|May 14, 2020
The biopharmaceutical company has seen shares rise 44.5% in less than two months.
3 Small-Cap Biotech Stocks That Surged Last Week
Cory Renauer|May 11, 2020
Here's what's behind their impressive market performances.
4 Stocks Battling Breast Cancer
David Haen|Oct 26, 2019
With Breast Cancer Awareness Month drawing to a close and the San Antonio Breast Cancer Symposium on the horizon, stay alert for breaking news from companies developing new treatments.
3 Biotechs That Have Doubled This Year (Acquisition Next?)
Brian Orelli, PhD|Jul 2, 2019
Good news has a way of attracting suitors.
3 Cancer Treatment Stocks to Buy Right Now
Keith Speights, Chuck Saletta, and Todd Campbell|May 23, 2019
These companies could make a big difference in how the disease is diagnosed and treated. And their stocks could make a big difference for long-term investors.
3 Stocks With Big News Coming at ASCO 2019
Todd Campbell|May 15, 2019
These cancer drug developers could report market-moving news soon.
